Barrington, R E <br/><br/>
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.  [electronic resource] 

 -  Molecular and cellular biology  Jan 1998 
 - 85-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-7306 
<br/><br/><label>Standard No.: </label>10.1128/MCB.18.1.85  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkyl and Aryl Transferases--antagonists & inhibitors<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma--drug therapy<br/>Cell Cycle--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Farnesyltranstransferase<br/>Female<br/>Genes, ras<br/>Humans<br/>Mammary Neoplasms, Experimental--drug therapy<br/>Mammary Tumor Virus, Mouse<br/>Methionine--analogs & derivatives<br/>Mice<br/>Mice, Transgenic<br/>Salivary Gland Neoplasms--drug therapy